MOlecular evolution of GPCRs: GLP1/GLP1 receptors

Journal of Molecular Endocrinology

Volumn 52, Issue 3, 2014, Pages

  Hwang, Jong Ik ^a   Yun, Seongsik ^a   Moon, Mi Jin ^a   Park, Cho Rong ^a   Seong, Jae Young ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Duplication; Evolution; Exon; G protein coupled receptor; Gene; Genome; GLP1; GLP1R

Indexed keywords

G PROTEIN COUPLED RECEPTOR; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; SECRETIN; GLP1R PROTEIN, HUMAN; GLUCAGON RECEPTOR; GLUCOSE; INSULIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CHEMICAL PHENOMENA; EXON; GENE DUPLICATION; GENOME; HUMAN; MOLECULAR EVOLUTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; ANIMAL; GENETICS; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; SECRETION (PROCESS); VERTEBRATE;

AMINO ACID SEQUENCE; ANIMALS; DIABETES MELLITUS, TYPE 2; EVOLUTION, MOLECULAR; GENE DUPLICATION; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-LIKE PEPTIDE-1 RECEPTOR; GLUCOSE; HUMANS; INSULIN; OBESITY; RECEPTORS, GLUCAGON; VERTEBRATES;

EID: 84901440166     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-13-0137     Document Type: Review

References (92)

1. Abi-Rached L., Gilles A, Shiina T, Pontarotti P & Inoko H 2002 Evidence of en bloc duplication in vertebrate genomes. Nature Genetics 31 100-105. (doi:10.1038/ng855)
2. Acharjee S., Do-Rego JL, Oh DY, Ahn RS, Choe H, Vaudry H, Kim K, Seong JY & Kwon HB 2004 Identification of amino acid residues that direct differential ligand selectivity of mammalian and nonmammalian V1a type receptors for arginine vasopressin and vasotocin. Insights into molecular coevolution of V1a type receptors and their ligands. Journal of Biological Chemistry 279 54445-54453. (doi:10.1074/jbc. M408909200)
3. Adelhorst K., Hedegaard BB, Knudsen LB & Kirk O 1994 Structure-activity studies of glucagon-like peptide-1. Journal of Biological Chemistry 269 6275-6278.
4. Alana I., Malthouse JP, O'Harte FP & Hewage CM 2007 The bioactive conformation of glucose-dependent insulinotropic polypeptide by NMR and CD spectroscopy. Proteins 68 92-99. (doi:10.1002/prot. 21372)
5. Al-Sabah S. & Donnelly D 2003 A model for receptor-peptide binding at the glucagon-like peptide-1 (GLP-1) receptor through the analysis of truncated ligands and receptors. British Journal of Pharmacology 140 339-346. (doi:10.1038/sj.bjp.0705453)
6. Alvarez E., Martinez MD, Roncero I, Chowen JA, Garcia-Cuartero B, Gispert J. D, Sanz C, Vazquez P, Maldonado A, de Caceres J et al. 2005 The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem. Journal of Neurochemistry 92 798-806. (doi:10.1111/j.1471-4159.2004.02914.x)
7. Baggio L. L & Drucker DJ 2002 Harnessing the therapeutic potential of glucagon-like peptide-1: a critical review. Treatments in Endocrinology 1 117-125. (doi:10.2165/00024677-200201020-00005)
8. Cardoso J. C, Pinto VC, Vieira FA, Clark MS & Power DM 2006 Evolution of secretin family GPCR members in the metazoa. BMC Evolutionary Biology 6 108. (doi:10.1186/1471-2148-6-108)
9. Cardoso J. C, Vieira FA, Gomes AS & Power DM 2010 The serendipitous origin of chordate secretin peptide family members. BMC Evolutionary Biology 10 135. (doi:10.1186/1471-2148-10-135)
10. Chen Q., Pinon DI, Miller LJ & Dong M 2009 Molecular basis of glucagon-like peptide 1 docking to its intact receptor studied with carboxyl-terminal photolabile probes. Journal of Biological Chemistry 284 34135-34144. (doi:10.1074/jbc.M109.038109)
11. Chen Q., Pinon DI, Miller LJ & Dong M 2010 Spatial approximations between residues 6 and 12 in the amino-terminal region of glucagonlike peptide 1 and its receptor: a region critical for biological activity. Journal of Biological Chemistry 285 24508-24518. (doi:10.1074/jbc. M110.135749)
12. Cho H. J, Acharjee S, Moon MJ, Oh DY, Vaudry H, Kwon HB & Seong JY 2007 Molecular evolution of neuropeptide receptors with regard to maintaining high affinity to their authentic ligands. General and Comparative Endocrinology 153 98-107. (doi:10.1016/j.ygcen.2006.12.013)
13. Coopman K., Wallis R, Robb G, Brown AJ, Wilkinson GF, Timms D & Willars G. B 2011 Residues within the transmembrane domain of the glucagon-like peptide-1 receptor involved in ligand binding and receptor activation: modelling the ligand-bound receptor. Molecular Endocrinology 25 1804-1818. (doi:10.1210/me.2011-1160)
14. DaCambra M. P, Yusta B, Sumner-Smith M, Crivici A, Drucker DJ & Brubaker P. L 2000 Structural determinants for activity of glucagon-like peptide-2. Biochemistry 39 8888-8894. (doi:10.1021/bi000497p)
15. Drucker D. J 2003 Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis. Molecular Endocrinology 17 161-171. (doi:10.1210/me.2002-0306)
16. Drucker D. J, Philippe J, Mojsov S, Chick WL & Habener JF 1987 Glucagonlike peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. PNAS 84 3434-3438. (doi:10.1073/ pnas.84.10.3434)
17. During M. J, Cao L, Zuzga DS, Francis JS, Fitzsimons HL, Jiao X, Bland RJ, Klugmann M., Banks WA, Drucker DJ et al. 2003 Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nature Medicine 9 1173-1179. (doi:10.1038/nm919)
18. Fehmann H. C & Habener JF 1992 Insulinotropic hormone glucagon-like peptide-I(7-37) stimulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma βTC-1 cells. Endocrinology 130 159-166. (doi:10.1210/en.130.1.159)
19. Fehmann H. C, Goke R & Goke B 1995 Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide. Endocrine Reviews 16 390-410.
20. Fredriksson R., Lagerstrom MC, Lundin LG & Schioth HB 2003 The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Molecular Pharmacology 63 1256-1272. (doi:10.1124/mol.63.6.1256)
21. Gallwitz B., Witt M, Paetzold G, Morys-Wortmann C, Zimmermann B, Eckart K., Folsch UR & Schmidt WE 1994 Structure/activity characterization of glucagon-like peptide-1. European Journal of Biochemistry 225 1151-1156. (doi:10.1111/j.1432-1033.1994.1151b.x)
22. Grace C. R, Perrin MH, DiGruccio MR, Miller CL, Rivier JE, Vale WW & Riek R. 2004 NMR structure and peptide hormone binding site of the first extracellular domain of a type B1 G protein-coupled receptor. PNAS 101 12836-12841. (doi:10.1073/pnas.0404702101)
23. Graziano M. P, Hey PJ, Borkowski D, Chicchi GG & Strader CD 1993 Cloning and functional expression of a human glucagon-like peptide-1 receptor. Biochemical and Biophysical Research Communications 196 141-146. (doi:10.1006/bbrc.1993.2226)
24. Hansotia T. & Drucker DJ 2005 GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice. Regulatory Peptides 128 125-134. (doi:10.1016/j.regpep.2004.07.019)
25. Harmar A. J 2001 Family-B G-protein-coupled receptors. Genome Biology 2 REVIEWS3013. (doi:10.1186/gb-2001-2-12-reviews3013)
26. Hewes R. S & Taghert PH 2001 Neuropeptides and neuropeptide receptors in the Drosophila melanogaster genome. Genome Research 11 1126-1142. (doi:10.1101/gr.169901)
27. Hinke S. A, Gelling R, Manhart S, Lynn F, Pederson RA, Kuhn-Wache K, Rosche F., Demuth HU, Coy D & McIntosh CH 2003 Structure-activity relationships of glucose-dependent insulinotropic polypeptide (GIP). Biological Chemistry 384 403-407. (doi:10.1515/BC.2003.046)
28. Hisadome K., Reimann F, Gribble FM & Trapp S 2010 Leptin directly depolarizes preproglucagon neurons in the nucleus tractus solitarius: electrical properties of glucagon-like peptide 1 neurons. Diabetes 59 1890-1898. (doi:10.2337/db10-0128)
29. Holland P. W 2003 More genes in vertebrates? Journal of Structural and Functional Genomics 3 75-84. (doi:10.1023/A:1022656931587)
30. Hwang J. I, Moon MJ, Park S, Kim DK, Cho EB, Ha N, Son GH, Kim K, Vaudry H. & Seong JY 2013 Expansion of secretin-like G proteincoupled receptors and their peptide ligands via local duplications before and after two rounds of whole-genome duplication. Molecular Biology and Evolution 30 1119-1130. (doi:10.1093/molbev/mst031)
31. Irwin D. M & Prentice KJ 2011 Incretin hormones and the expanding families of glucagon-like sequences and their receptors. Diabetes, Obesity & Metabolism 13 (Suppl 1) 69-81. (doi:10.1111/j.1463-1326. 2011.01444.x)
32. Irwin D. M & Wong K 2005 Evolution of new hormone function: loss and gain of a receptor. Journal of Heredity 96 205-211. (doi:10.1093/jhered/ esi024)
33. Irwin D. M, Satkunarajah M, Wen Y, Brubaker PL, Pederson RA & Wheeler M. B 1997 The Xenopus proglucagon gene encodes novel GLP-1-like peptides with insulinotropic properties. PNAS 94 7915-7920. (doi:10.1073/pnas.94.15.7915)
34. Irwin D. M, Huner O &Youson JH 1999 Lamprey proglucagon and the origin of glucagon-like peptides. Molecular Biology and Evolution 16 1548-1557. (doi:10.1093/oxfordjournals.molbev.a026067)
35. Ishihara T., Nakamura S, Kaziro Y, Takahashi T, Takahashi K & Nagata S 1991 Molecular cloning and expression of a cDNA encoding the secretin receptor. EMBO Journal 10 1635-1641.
36. 2+ release in INS-1 pancreatic β-cells. Journal of Physiology 536 375-385. (doi:10.1111/j.1469-7793.2001.0375c.xd)
37. Kieffer T. J & Habener JF 1999 The glucagon-like peptides. Endocrine Reviews 20 876-913. (doi:10.1210/er.20.6.876)
38. Kim D. K, Cho EB, Moon MJ, Park S, Hwang JI, Kah O, Sower SA, Vaudry H & Seong J. Y 2011 Revisiting the evolution of gonadotropin-releasing hormones and their receptors in vertebrates: secrets hidden in genomes. General and Comparative Endocrinology 170 68-78. (doi:10.1016/j.ygcen.2010.10.018)
39. Kim D. K, Cho EB, Moon MJ, Park S, Hwang JI, Do Rego JL, Vaudry H & Seong J. Y 2012 Molecular coevolution of neuropeptides gonadotropin-releasing hormone and kisspeptin with their cognate G protein-coupled receptors. Frontiers in Neuroscience 6 3. (doi:10.3389/ fnins.2012.00003)
40. Kirkpatrick A., Heo J, Abrol R & GoddardWA III 2012 Predicted structure of agonist-bound glucagon-like peptide 1 receptor, a class B G protein-coupled receptor. PNAS 109 19988-19993. (doi:10.1073/pnas. 1218051109)
41. Koole C., Wootten D, Simms J, Miller LJ, Christopoulos A & Sexton PM 2012 Second extracellular loop of human glucagon-like peptide-1 receptor (GLP-1R) has a critical role in GLP-1 peptide binding and receptor activation. Journal of Biological Chemistry 287 3642-3658. (doi:10.1074/ jbc.M111.309328)
42. Koth C. M, Murray JM, Mukund S, Madjidi A, Minn A, Clarke HJ, Wong T, Chiang V., Luis E, Estevez A et al. 2012 Molecular basis for negative regulation of the glucagon receptor. PNAS 109 14393-14398. (doi:10.1073/pnas.1206734109)
43. Laburthe M., Couvineau A, Gaudin P, Maoret JJ, Rouyer-Fessard C & Nicole P. 1996 Receptors for VIP, PACAP, secretin, GRF, glucagon, GLP-1, and other members of their new family of G protein-linked receptors: structure-function relationship with special reference to the human VIP-1 receptor. Annals of the New York Academy of Sciences 805 94-109 (discussion 110-111). (doi:10.1111/j.1749-6632.1996.tb17476.x)
44. Larhammar D., Lundin LG & Hallbook F 2002 The human Hox-bearing chromosome regions did arise by block or chromosome (or even genome) duplications. Genome Research 12 1910-1920. (doi:10.1101/ gr.445702)
45. Lee Y. R, Tsunekawa K, Moon MJ, Um HN, Hwang JI, Osugi T, Otaki N, Sunakawa Y., Kim K, Vaudry H et al. 2009 Molecular evolution of multiple forms of kisspeptins and GPR54 receptors in vertebrates. Endocrinology 150 2837-2846. (doi:10.1210/en.2008-1679)
46. Li Y., Hansotia T, Yusta B, Ris F, Halban PA & Drucker DJ 2003 Glucagon-like peptide-1 receptor signaling modulates β-cell apoptosis. Journal of Biological Chemistry 278 471-478. (doi:10.1074/jbc.M209423200)
47. Li J. H, Choe H, Wang AF, Maiti K, Wang C, Salam A, Chun SY, Lee WK, Kim K., Kwon HB et al. 2005 Extracellular loop 3 (EL3) and EL3-proximal transmembrane helix 7 of the mammalian type I and type II gonadotropin-releasing hormone (GnRH) receptors determine differential ligand selectivity to GnRH-I and GnRH-II. Molecular Pharmacology 67 1099-1110. (doi:10.1124/mol.104.004887)
48. Lin F. & Wang R 2009 Molecular modeling of the three-dimensional structure of GLP-1R and its interactions with several agonists. Journal of Molecular Modeling 15 53-65. (doi:10.1007/s00894-008-0372-2)
49. Lopez de Maturana R & Donnelly D 2002 The glucagon-like peptide-1 receptor binding site for the N-terminus of GLP-1 requires polarity at Asp198 rather than negative charge. FEBS Letters 530 244-248. (doi:10.1016/S0014-5793(02)03492-0)
50. Lopez de Maturana R, Treece-Birch J, Abidi F, Findlay JB & Donnelly D 2004 Met-204 and Tyr-205 are together important for binding GLP-1 receptor agonists but not their N-terminally truncated analogues. Protein and Peptide Letters 11 15-22. (doi:10.2174/ 0929866043478491)
51. Mirabeau O. & Joly JS 2013 Molecular evolution of peptidergic signaling systems in bilaterians. PNAS 110 E2028-E2037. (doi:10.1073/pnas. 1219956110)
52. Mojsov S., Heinrich G, Wilson IB, Ravazzola M, Orci L & Habener JF 1986 Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. Journal of Biological Chemistry 261 11880-11889.
53. Mojsov S., Kopczynski MG & Habener JF 1990 Both amidated and nonamidated forms of glucagon-like peptide I are synthesized in the rat intestine and the pancreas. Journal of Biological Chemistry 265 8001-8008.
54. Moon M. J, Kim HY, Kim SG, Park J, Choi DS, Hwang JI & Seong JY 2010 Tyr1 and Ile7 of glucose-dependent insulinotropic polypeptide (GIP) confer differential ligand selectivity toward GIP and glucagon-like peptide-1 receptors. Molecules and Cells 30 149-154. (doi:10.1007/s10059-010-0100-5)
55. Moon M. J, Kim HY, Park S, Kim DK, Cho EB, Hwang JI & Seong JY 2011 Insulin contributes to fine-tuning of the pancreatic β-cell response to glucagon-like peptide-1. Molecules and Cells 32 389-395. (doi:10.1007/ s10059-011-0157-9)
56. Moon M. J, Kim HY, Park S, Kim DK, Cho EB, Park CR, You DJ, Hwang JI, Kim K., Choe H et al. 2012a Evolutionarily conserved residues at glucagon-like peptide-1 (GLP-1) receptor core confer ligand-induced receptor activation. Journal of Biological Chemistry 287 3873-3884. (doi:10.1074/jbc.M111.276808)
57. Moon M. J, Park S, Kim DK, Cho EB, Hwang JI, Vaudry H & Seong JY 2012b Structural and molecular conservation of glucagon-like peptide-1 and its receptor confers selective ligand-receptor interaction. Frontiers in Endocrinology 3 141. (doi:10.3389/fendo.2012.00141)
58. Nakatani Y., Takeda H, Kohara Y & Morishita S 2007 Reconstruction of the vertebrate ancestral genome reveals dynamic genome reorganization in early vertebrates. Genome Research 17 1254-1265. (doi:10.1101/ gr.6316407)
59. Nauck M. A, Heimesaat MM, Behle K, Holst JJ, Nauck MS, Ritzel R, HufnerM & Schmiegel WH 2002 Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers. Journal of Clinical Endocrinology and Metabolism 87 1239-1246. (doi:10.1210/jc.87.3.1239)
60. Neidigh J. W, Fesinmeyer RM, Prickett KS & Andersen NH 2001 Exendin-4 and glucagon-like-peptide-1: NMR structural comparisons in the solution and micelle-associated states. Biochemistry 40 13188-13200. (doi:10.1021/bi010902s)
61. Neumann J. M, Couvineau A, Murail S, Lacapere JJ, Jamin N & Laburthe M 2008 Class-B GPCR activation: is ligand helix-capping the key? Trends in Biochemical Sciences 33 314-319. (doi:10.1016/j.tibs.2008.05.001)
62. Ng S. Y, Chow BK, Kasamatsu J, Kasahara M & Lee LT 2012 Agnathan VIP, PACAP and their receptors: ancestral origins of today's highly diversified forms. PLoS ONE 7 e44691. (doi:10.1371/journal.pone. 0044691)
63. Nguyen T. M, Mommsen TP, Mims SM & Conlon JM 1994 Characterization of insulins and proglucagon-derived peptides from a phylogenetically ancient fish, the paddlefish (Polyodon spathula). Biochemical Journal 300 339-345.
64. Nordstrom K. J, Fredriksson R & Schioth HB 2008 The amphioxus (Branchiostoma floridae) genome contains a highly diversified set of G protein-coupled receptors. BMC Evolutionary Biology 8 9. (doi:10.1186/ 1471-2148-8-9)
65. Oh D. Y, Kim K, Kwon HB & Seong JY 2006 Cellular and molecular biology of orphan G protein-coupled receptors. International Review of Cytology 252 163-218.
66. Park C. R, Moon MJ, Park S, Kim D-K, Cho EB, Millar RP, Hwang J-I & Seong J. Y 2013 A novel glucagon-related peptide (GCRP) and its receptor GCRPR account for coevolution of their family members in vertebrates. PLoS ONE 8 e65420. (doi:10.1371/journal.pone.0065420)
67. Parthier C., Kleinschmidt M, Neumann P, Rudolph R, Manhart S, Schlenzig D., Fanghanel J, Rahfeld JU, Demuth HU & Stubbs MT 2007 Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor. PNAS 104 13942-13947. (doi:10.1073/pnas. 0706404104)
68. Perret J., Van Craenenbroeck M, Langer I, Vertongen P, Gregoire F, Robberecht P. & Waelbroeck M 2002 Mutational analysis of the glucagon receptor: similarities with the vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide (PACAP)/secretin receptors for recognition of the ligand's third residue. Biochemical Journal 362 389-394. (doi:10.1042/0264-6021:3620389)
69. Perry T., Holloway HW, Weerasuriya A, Mouton PR, Duffy K, Mattison JA & Greig N. H 2007 Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy. Experimental Neurology 203 293-301. (doi:10.1016/j.expneurol.2006. 09.028)
70. Putnam N. H, Butts T, Ferrier DE, Furlong RF, Hellsten U, Kawashima T, Robinson-Rechavi M., Shoguchi E, Terry A, Yu JK et al. 2008 The amphioxus genome and the evolution of the chordate karyotype. Nature 453 1064-1071. (doi:10.1038/nature06967)
71. Runge S., Gram C, Brauner-Osborne H, Madsen K, Knudsen LB & Wulff BS 2003a Three distinct epitopes on the extracellular face of the glucagon receptor determine specificity for the glucagon amino terminus. Journal of Biological Chemistry 278 28005-28010. (doi:10.1074/jbc. M301085200)
72. Runge S., Wulff BS, Madsen K, Brauner-Osborne H & Knudsen LB 2003b Different domains of the glucagon and glucagon-like peptide-1 receptors provide the critical determinants of ligand selectivity. British Journal of Pharmacology 138 787-794. (doi:10.1038/sj.bjp.0705120)
73. Runge S., Thogersen H, Madsen K, Lau J & Rudolph R 2008 Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain. Journal of Biological Chemistry 283 11340-11347. (doi:10.1074/ jbc.M708740200)
74. Santini S., Boore JL & Meyer A 2003 Evolutionary conservation of regulatory elements in vertebrate Hox gene clusters. Genome Research 13 1111-1122. (doi:10.1101/gr.700503)
75. Schmidt W. E, Siegel EG & Creutzfeldt W 1985 Glucagon-like peptide-1 but not glucagon-like peptide-2 stimulates insulin release from isolated rat pancreatic islets. Diabetologia 28 704-707. (doi:10.1007/BF00291980)
76. Sherwood N. M, Krueckl SL &McRory JE 2000 The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily. Endocrine Reviews 21 619-670. (doi:10.1210/er.21.6.619)
77. Siu F. Y, He M, de Graaf C, Han GW, Yang D, Zhang Z, Zhou C, Xu Q, Wacker D., Joseph JS et al. 2013 Structure of the human glucagon class B G-protein-coupled receptor. Nature 499 444-449. (doi:10.1038/ nature12393)
78. Thornton K. & Gorenstein DG 1994 Structure of glucagon-like peptide (7-36) amide in a dodecylphosphocholinemicelle as determined by 2D NMR. Biochemistry 33 3532-3539. (doi:10.1021/bi00178a009)
79. Underwood C. R, Garibay P, Knudsen LB, Hastrup S, Peters GH, Rudolph R & Reedtz-Runge S. 2010 Crystal structure of glucagon-like peptide-1 in complex with the extracellular domain of the glucagon-like peptide-1 receptor. Journal of Biological Chemistry 285 723-730. (doi:10.1074/jbc. M109.033829)
80. Venneti K. C & Hewage CM 2011 Conformational and molecular interaction studies of glucagon-like peptide-2 with its N-terminal extracellular receptor domain. FEBS Letters 585 346-352. (doi:10.1016/ j.febslet.2010.12.011)
81. Vienne A., Rasmussen J, Abi-Rached L, Pontarotti P & Gilles A 2003 Systematic phylogenomic evidence of en bloc duplication of the ancestral 8p11.21-8p21.3-like region. Molecular Biology and Evolution 20 1290-1298. (doi:10.1093/molbev/msg127)
82. Vrang N., Hansen M, Larsen PJ & Tang-Christensen M 2007 Characterization of brainstem preproglucagon projections to the paraventricular and dorsomedial hypothalamic nuclei. Brain Research 1149 118-126. (doi:10.1016/j.brainres.2007.02.043)
83. Wang C., Yun O, Maiti K, Oh DY, Kim KK, Chae CH, Lee CJ, Seong JY & Kwon H. B 2004 Position of Pro and Ser near Glu7.32 in the extracellular loop 3 of mammalian and nonmammalian gonadotropinreleasing hormone (GnRH) receptors is a critical determinant for differential ligand selectivity for mammalian GnRH and chicken GnRH-II. Molecular Endocrinology 18 105-116. (doi:10.1210/ me.2003-0101)
84. Wang Y., Li J, Wang CY, Kwok AY, Zhang X & Leung FC 2010 Characterization of the receptors for chicken GHRH and GHRH-related peptides: identification of a novel receptor for GHRH and the receptor for GHRH-LP (PRP). Domestic Animal Endocrinology 38 13-31. (doi:10.1016/j.domaniend.2009.07.008)
85. Wang Y., Meng F, Zhong Y, Huang G & Li J 2012 Discovery of a novel glucagon-like peptide (GCGL) and its receptor (GCGLR) in chickens: evidence for the existence of GCGL and GCGLR genes in nonmammalian vertebrates. Endocrinology 153 5247-5260. (doi:10.1210/ en.2012-1586)
86. Wei Y& Mojsov S 1995 Tissue-specific expression of the human receptor for glucagon-like peptide-I: brain, heart and pancreatic forms have the same deduced amino acid sequences. FEBS Letters 358 219-224. (doi:10.1016/0014-5793(94)01430-9)
87. Wheeler M. B, Lu M, Dillon JS, Leng XH, Chen C & Boyd AE III 1993 Functional expression of the rat glucagon-like peptide-I receptor, evidence for coupling to both adenylyl cyclase and phospholipase-C. Endocrinology 133 57-62. (doi:10.1210/en.133.1.57)
88. Xiao Q., Jeng W & Wheeler MB 2000 Characterization of glucagon-like peptide-1 receptor-binding determinants. Journal of Molecular Endocrinology 25 321-335. (doi:10.1677/jme.0.0250321)
89. Xu G., Stoffers DA, Habener JF & Bonner-Weir S 1999 Exendin-4 stimulates both β-cell replication and neogenesis, resulting in increased β-cell mass and improved glucose tolerance in diabetic rats. Diabetes 48 2270-2276. (doi:10.2337/diabetes.48.12.2270)
90. Yaqub T., Tikhonova IG, Lattig J, Magnan R, Laval M, Escrieut C, Boulegue C, Hewage C. & Fourmy D 2010 Identification of determinants of glucosedependent insulinotropic polypeptide receptor that interact with N-terminal biologically active region of the natural ligand. Molecular Pharmacology 77 547-558. (doi:10.1124/mol.109.060111)
91. Yegorov S. & Good S 2012 Using paleogenomics to study the evolution of gene families: origin and duplication history of the relaxin family hormones and their receptors. PLoS ONE 7 e32923. (doi:10.1371/ journal.pone.0032923)
92. Zander M., Madsbad S, Madsen JL & Holst JJ 2002 Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study. Lancet 359 824-830. (doi:10.1016/S0140-6736(02)07952-7)